These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16503145)

  • 1. Recent trends in the concept of specific activity: impact on radiochemical and radiopharmaceutical producers.
    Zeevaart JR; Olsen S
    Appl Radiat Isot; 2006 Jul; 64(7):812-4. PubMed ID: 16503145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NIST radioactivity measurement assurance program for the radiopharmaceutical industry.
    Cessna JT; Golas DB
    Appl Radiat Isot; 2012 Sep; 70(9):2227-31. PubMed ID: 22578995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodination of proteins using prosthetic group: a convenient way to produce labelled proteins with in vivo stability.
    Santos JS; Muramoto E; Colturato MT; Siva CP; Araújo EB
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):735-9. PubMed ID: 12619967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic and practical concepts of radiopharmaceutical purification methods.
    Molavipordanjani S; Tolmachev V; Hosseinimehr SJ
    Drug Discov Today; 2019 Jan; 24(1):315-324. PubMed ID: 30278224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemical purity of routinely prepared 99Tcm radiopharmaceuticals: a retrospective study.
    Decristoforo C; Siller R; Chen F; Riccabona G
    Nucl Med Commun; 2000 Apr; 21(4):349-54. PubMed ID: 10845223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based approach to the analysis of radiopharmaceuticals: radiochemical purity, specific activity, and radioactive concentration values by proton and tritium NMR spectroscopy.
    Schenk DJ; Dormer PG; Hesk D; Pollack SR; Lavey CF
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):291-8. PubMed ID: 26014438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific case of radiopharmaceuticals and GMP--activities of the Radiopharmacy Committee.
    Decristoforo C; Elsinga P; Faivre-Chauvet A; Farstad B; Meyer G; Mikolajczak R; Penuelas I; Unak P; Westera G;
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1400-1. PubMed ID: 18481061
    [No Abstract]   [Full Text] [Related]  

  • 8. True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?
    Eckelman WC; Bonardi M; Volkert WA
    Nucl Med Biol; 2008 Jul; 35(5):523-7. PubMed ID: 18589295
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid and efficient purification of positron emission tomography probes by hydrophilic interaction chromatography.
    Nakao R; Ito T; Hayashi K; Fukumura T; Suzuki K
    J Chromatogr A; 2009 May; 1216(18):3933-40. PubMed ID: 19307000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple and rapid technique for radiochemical separation of iodine radionuclides from irradiated tellurium using an activated charcoal column.
    Chattopadhyay S; Saha Das S
    Appl Radiat Isot; 2009 Oct; 67(10):1748-50. PubMed ID: 19410470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of hard gelatin capsules for oral delivery of aqueous radiopharmaceuticals.
    Omar SM; Abdel-Rashid RS; AlAssaly MK; Sakr TM
    Daru; 2019 Jun; 27(1):295-305. PubMed ID: 31175641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GMP production.Shaping the future].
    Wester HJ
    Nuklearmedizin; 2012; 51(1):N1-4. PubMed ID: 22448395
    [No Abstract]   [Full Text] [Related]  

  • 14. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
    Donovan AC; Valliant JF
    Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different counting methods for use in radiochemical purity testing procedures for 99mTc-labelled radiopharmaceuticals.
    Maioli C; Bestetti A; Milani F; Cornalba GP; Tagliabue L; Di Benedetto D; Rognoni I; Luigi Tarolo G; Paroni R
    Appl Radiat Isot; 2008 Apr; 66(4):556-9. PubMed ID: 17851085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.
    Herzog H; Tellmann L; Scholten B; Coenen HH; Qaim SM
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):159-65. PubMed ID: 18043538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmaceutical space.
    Eckelman WC; Kilbourn MR; Mathis CA
    Nucl Med Biol; 2006 Oct; 33(7):829. PubMed ID: 17045161
    [No Abstract]   [Full Text] [Related]  

  • 18. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.
    Jobson NK; Crawford AR; Dewar D; Pimlott SL; Sutherland A
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4996-8. PubMed ID: 19640707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Minute quality control tests for positron emission tomography radiopharmaceuticals.
    Nakao R; Ito T; Hayashi K; Fukumura T; Yamaguchi M; Suzuki K
    J Pharm Biomed Anal; 2009 Sep; 50(2):245-51. PubMed ID: 19442471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.